[1-Benzyl-1,2,5-methyl-3-isoxazolylcarbonylhydrazine, a monoaminooxidase inhibitor, in the treatment of 84 depressed patients].
D003863:Depression / Q000628:therapy*; D003866:Depressive Disorder; D010088:Oxidoreductases / Q000037:antagonists & inhibitors*; D011600:Psychopharmacology
D010088:Oxidoreductases
DEPRESSION/therapy; OXIDASES/antagonists; PSYCHOPHARMACOLOGY